Literature DB >> 33919351

Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.

Sara Mucherino1,2, Antonio Gimeno-Miguel3,4, Jonas Carmona-Pirez3,4, Francisca Gonzalez-Rubio3,4,5, Ignatios Ioakeim-Skoufa3,5,6, Aida Moreno-Juste3,4, Valentina Orlando1,2, Mercedes Aza-Pascual-Salcedo3,4, Beatriz Poblador-Plou3,4, Enrica Menditto1,2, Alexandra Prados-Torres3,4.   

Abstract

The pressing problem of multimorbidity and polypharmacy is aggravated by the lack of specific care models for this population. We aimed to investigate the evolution of multimorbidity and polypharmacy patterns in a given population over a 4-year period (2011-2015). A cross-sectional, observational study among the EpiChron Cohort, including anonymized demographic, clinical and drug dispensation information of all users of the public health system ≥65 years in Aragon (Spain), was performed. An exploratory factor analysis, stratified by age and sex, using an open cohort was carried out based on the tetra-choric correlations among chronic diseases and dispensed drugs during 2011 and compared with 2015. Seven baseline patterns were identified during 2011 named as: mental health, respiratory, allergic, mechanical pain, cardiometabolic, osteometabolic, and allergic/derma. Of the epidemiological patterns identified in 2015, six were already present in 2011 but a new allergic/derma one appeared. Patterns identified in 2011 were more complex in terms of both disease and drugs. Results confirmed the existing association between age and clinical complexity. The systematic associations between diseases and drugs remain similar regarding their clinical nature over time, helping in early identification of potential interactions in multimorbid patients with a high risk of negative health outcomes due to polypharmacy.

Entities:  

Keywords:  chronic diseases; epidemiology; multimorbidity; polypharmacy; real-world data

Year:  2021        PMID: 33919351     DOI: 10.3390/ijerph18094422

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  35 in total

Review 1.  The genetics of asthma and allergic disorders.

Authors:  Michael E March; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

Review 2.  Overcoming problems with polypharmacy and drug misuse in the elderly.

Authors:  S C Montamat; B Cusack
Journal:  Clin Geriatr Med       Date:  1992-02       Impact factor: 3.076

3.  Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications.

Authors:  Sara Malo; Isabel Aguilar-Palacio; Cristina Feja; María Jesús Lallana; María José Rabanaque; Javier Armesto; Enrica Menditto
Journal:  Curr Med Res Opin       Date:  2017-05-19       Impact factor: 2.580

Review 4.  Multimorbidity patterns: a systematic review.

Authors:  Alexandra Prados-Torres; Amaia Calderón-Larrañaga; Jorge Hancco-Saavedra; Beatriz Poblador-Plou; Marjan van den Akker
Journal:  J Clin Epidemiol       Date:  2014-03       Impact factor: 6.437

Review 5.  Sex-Related Allergic Rhinitis Prevalence Switch from Childhood to Adulthood: A Systematic Review and Meta-Analysis.

Authors:  Mariona Pinart; Theresa Keller; Andreas Reich; Matthias Fröhlich; Báltica Cabieses; Cynthia Hohmann; Dirkje S Postma; Jean Bousquet; Josep M Antó; Thomas Keil
Journal:  Int Arch Allergy Immunol       Date:  2017-04-29       Impact factor: 2.749

6.  Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis.

Authors:  Alexandra Prados-Torres; Beatriz Poblador-Plou; Amaia Calderón-Larrañaga; Luis Andrés Gimeno-Feliu; Francisca González-Rubio; Antonio Poncel-Falcó; Antoni Sicras-Mainar; José Tomás Alcalá-Nalvaiz
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

7.  Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden.

Authors:  Yasmina Molero; Henrik Larsson; Brian M D'Onofrio; David J Sharp; Seena Fazel
Journal:  BMJ       Date:  2019-06-12

8.  [Towards a multimorbidity care model in Primary Care].

Authors:  Daniel Prados-Torres; Isabel Del Cura-González; Alexandra Prados-Torres
Journal:  Aten Primaria       Date:  2017-01-11       Impact factor: 1.137

9.  Somatic symptoms and their association with anxiety and depression in Chinese patients with cardiac neurosis.

Authors:  Feng Zheng; Yinglong Duan; Jingle Li; Lin Lai; Zhuqing Zhong; Manhui Hu; Siqing Ding
Journal:  J Int Med Res       Date:  2019-08-26       Impact factor: 1.671

10.  Potentially inappropriate prescribing among older people in the United Kingdom.

Authors:  Marie C Bradley; Nicola Motterlini; Shivani Padmanabhan; Caitriona Cahir; Tim Williams; Tom Fahey; Carmel M Hughes
Journal:  BMC Geriatr       Date:  2014-06-12       Impact factor: 3.921

View more
  3 in total

1.  Exploring Patient Multimorbidity and Complexity Using Health Insurance Claims Data: A Cluster Analysis Approach.

Authors:  Anna Nicolet; Dan Assouline; Joachim Marti; Isabelle Peytremann-Bridevaux; Marie-Annick Le Pogam; Clémence Perraudin; Christophe Bagnoud; Joël Wagner
Journal:  JMIR Med Inform       Date:  2022-04-04

2.  Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.

Authors:  Ignatios Ioakeim-Skoufa; Mercedes Clerencia-Sierra; Aida Moreno-Juste; Carmen Elías de Molins Peña; Beatriz Poblador-Plou; Mercedes Aza-Pascual-Salcedo; Francisca González-Rubio; Alexandra Prados-Torres; Antonio Gimeno-Miguel
Journal:  Int J Environ Res Public Health       Date:  2022-08-17       Impact factor: 4.614

3.  Trends in the Prescription of Benzodiazepine Receptor Agonists from 2009 to 2020: A Retrospective Study Using Electronic Healthcare Record Data of a University Hospital in Japan.

Authors:  Tasuku Okui; Jinsang Park; Akie Hirata; Naoki Nakashima
Journal:  Healthcare (Basel)       Date:  2021-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.